Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Arthritis & Rheumatism

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/art.30174PMID 21360497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th1 and Th17 cells

  2010cited by this paper
• Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis.

  2010cited by this paper
• Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling

  2009cited by this paper
• Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.

  2009cited by this paper
• Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1

  2009cited by this paper
• Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion

  2009cited by this paper
• Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model

  2009cited by this paper
• Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ production

  2009cited by this paper
• Prostaglandin E2 enhances Th17 responses via modulation of IL‐17 and IFN‐γ production by memory CD4+ T cells

  2009cited by this paper
• Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

  2009cited by this paper
• Molecules in focus: cytosolic phospholipase A2-alpha.

  2009cited by this paper
• RNA interference-based gene therapy for successful treatment of rheumatoid arthritis

  2009cited by this paper
• Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

  2008cited by this paper
• IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition

  2008cited by this paper
• Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.

  2008cited by this paper
• Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.

  2008cited by this paper
• Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

  2008cited by this paper
• Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

  2008cited by this paper
• Reduction of cPLA2α overexpression: An efficient anti‐inflammatory therapy for collagen‐induced arthritis

  2008cited by this paper
• Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.

  2007cited by this paper
• Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1

  2007cited by this paper
• Cells of the synovium in rheumatoid arthritis. Macrophages

  2007cited by this paper
• Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.

  2007cited by this paper
• The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23→IL-17 Axis1

  2007cited by this paper
• Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α

  2007cited by this paper
• Targeting cytosolic phospholipase A2 by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice.

  2006cited by this paper
• Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s.

  2006cited by this paper
• Properties of the Group IV phospholipase A2 family.

  2006cited by this paper
• Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.

  2006cited by this paper
• Immature Dendritic Cells Suppress Collagen-Induced Arthritis by In Vivo Expansion of CD49b+ Regulatory T Cells1

  2006cited by this paper
• Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

  2005cited by this paper
• Macrophage differentiation to foam cells.

  2005cited by this paper
• Cytosolic phospholipase A2α–deficient mice are resistant to experimental autoimmune encephalomyelitis

  2005cited by this paper
• Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: Kinetics of stromelysin and IL-1 mRNA levels during arthritis

  2005cited by this paper
• Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2.

  2004cited by this paper
• Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis.

  2004cited by this paper
• Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte‐like PLB‐985 cells: studies of differentiated cPLA2‐deficient PLB‐985 cells

  2004cited by this paper
• Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study

  2004cited by this paper
• Regulation of arachidonic acid availability for eicosanoid production.

  2004cited by this paper
• Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease.

  2004cited by this paper
• Cytosolic Phospholipase A 2 (cid:2) –deficient Mice Are Resistant to Collagen-induced Arthritis

  2003cited by this paper
• Elevated cytosolic phospholipase A(2) expression and activity in human neutrophils during sepsis.

  2000cited by this paper
• Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2

  1997cited by this paper
• Tumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells.

  1996cited by this paper
• Tumor necrosis factor-α induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells

  1996cited by this paper
• Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2.

  1994cited by this paper

• Therapeutic Potential of Nanocarriers in the Management of Rheumatoid Arthritis.

  2024cites this paper
• Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery

  2024cites this paper
• RNA antisense and silencing strategies using synthetic drugs for rare muscular and neuromuscular diseases

  2023cites this paper
• Recent advances in drug delivery approaches for rheumatoid arthritis.

  2023cites this paper
• Advance of the Biocompatible Hydrogels in Medical Applications

  2023cites this paper
• Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid Arthritis

  2021cites this paper
• Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis

  2021cites this paper
• Nanotechnology for diagnosis and therapy of rheumatoid arthritis: Evolution towards theranostic approaches

  2020cites this paper
• Towards gene therapy for rheumatoid arthritis

  2020cites this paper
• Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene therapy: A comprehensive review.

  2020cites this paper
• Toward gene therapy in rheumatoid arthritis

  2020cites this paper
• Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases

  2019cites this paper
• Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis

  2019cites this paper
• The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune Diseases.

  2018cites this paper
• Macrophages' Role in Tissue Disease and Regeneration.

  2017cites this paper
• Nanomedicines for dysfunctional macrophage-associated diseases.

  2017cites this paper
• 10 Gene Therapy Challenges in Arthritis

  2017cites this paper
• Utilization of nanoparticle technology in rheumatoid arthritis treatment.

  2016cites this paper
• Developing anti-inflammatory therapeutics for patients with osteoarthritis

  2016cites this paper
• Gene therapy of arthritis

  2016cites this paper
• Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia.

  2015cites this paper
• Gene Therapy for Autoimmune Disease

  2015cites this paper
• Molecular mechanisms of inflammation – a central role for cytosolic phospholipase A2

  2014cites this paper
• CARD11 blockade suppresses murine collagen‐induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response

  2014cites this paper
• Lipid-based nanoparticles in the systemic delivery of siRNA.

  2014cites this paper
• Cytosolic Phospholipase A2 Regulates TNF-Induced Production of Joint Destructive Effectors in Synoviocytes

  2013cites this paper
• siRNA-based therapeutic approaches for rheumatic diseases

  2013cites this paper
• Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.

  2013cites this paper
• Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis

  2013cites this paper
• Gene Therapy Challenges in Arthritis

  2011cites this paper
• Nanotherapeutic approaches for the treatment of rheumatoid

  2011cites this paper
• Grand challenges in modulating the immune response with RNAi nanomedicines.

  2011cites this paper
• Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

  2011cites this paper
• Integrative investigation of lipidome and signal pathways in human endothelial cells under oxidative stress.

  2011cites this paper